Show simple item record

Heterogeneity of the type I interferon signature in rheumatoid arthritis: A potential limitation for its use as a clinical biomarker

dc.contributor.authorRodríguez Carrio, Javier 
dc.contributor.authorAlperi López, Mercedes 
dc.contributor.authorLópez Suárez, Patricia 
dc.contributor.authorBallina García, Francisco Javier 
dc.contributor.authorSuárez Díaz, Ana María 
dc.date.accessioned2018-04-24T09:39:44Z
dc.date.available2018-04-24T09:39:44Z
dc.date.issued2018
dc.identifier.citationFrontiers in Immunology, 8(2007), (2018); doi:10.3389/fimmu.2017.02007
dc.identifier.issn1664-3224
dc.identifier.urihttp://hdl.handle.net/10651/46773
dc.description.sponsorshipThis work was supported by European Union FEDER funds and "Fondo de Investigacion Sanitaria" (FIS, PI12/00523 and PI16/00113; ISCIII, Spain), and SER/FER funds (Sociedad Espanola de Reumatologia, FER043/2016). JR-C is supported by a postdoctoral contract from the "Juan de la Cierva" program (FJCI-2015-23849; MINECO, Spain).
dc.language.isoeng
dc.relation.ispartofFrontiers in Immunology, 8
dc.rights© 2018 Rodriguez-Carrio et al.
dc.rightsCC Reconocimiento 4.0 Internacional
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScopus
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85040962063&doi=10.3389%2ffimmu.2017.02007&partnerID=40&md5=2d322bee13276f8d76fabce098983d87
dc.titleHeterogeneity of the type I interferon signature in rheumatoid arthritis: A potential limitation for its use as a clinical biomarker
dc.typejournal article
dc.identifier.doi10.3389/fimmu.2017.02007
dc.relation.projectIDFEDER/PI16/00113
dc.relation.projectIDMINECO/FJCI-2015-23849
dc.relation.publisherversionhttp://dx.doi.org/10.3389/fimmu.2017.02007
dc.rights.accessRightsopen access


Files in this item

untranslated

This item appears in the following Collection(s)

Show simple item record

© 2018 Rodriguez-Carrio et al.
This item is protected with a Creative Commons License